. (NASDAQ:QADA) (NASDAQ:QADB) announced today it has seen increased deployments among Medical Technology (
) manufacturers for
QAD On Demand Life Sciences
Edition, the cloud enterprise resource planning (ERP) solution. QAD On Demand is
full-strength cloud ERP
makes it easier
for Medtech to meet globalization challenges and allocate capital for business initiatives and product innovation.
“Globalization has transformed demand for medical technology, accelerated production processes and given rise to new economies,” said Dave Medina, vice president of Life Sciences at QAD. “To meet today’s globalization challenges and opportunities, Medtech manufacturers are moving to the
QAD global cloud
ERP to benefit from its simplicity, reliability, global capabilities and
QAD Cloud ERP Lets Medtech Focus on their Business and Product Innovation
QAD On Demand
Life Sciences Edition
full suite of ERP capabilities
and specific life sciences services to help QAD customers meet regulatory compliance. QAD cloud ERP allows Medtech manufacturers to focus on their business initiatives and product innovation – not their ERP software. The
QAD cloud ERP
model enables customers to eliminate capital expenditures associated with premise-based ERP software, hardware, system maintenance and support. QAD On Demand offers a robust and
solution. It is particularly scalable – and allows companies to standardize their ERP as they acquire new divisions, divest or pursue opportunities to rapidly scale operations in growth markets. QAD
support for local languages, currencies, business practices and legal requirements, enable Medtech manufacturers to efficiently align their global operations to
goals and perform at their best.
QAD Fully Qualified Cloud ERP – Built For Medical Technology Manufacturers
With QAD’s fully qualified IT environment and validation support tools, Medtech manufacturers can reduce the costs and effort of complying with regulatory requirements for software validation.
QAD Life Science
On Demand offers all the robust capabilities of
QAD On Demand
, but provides the necessary standard operating procedures (SOPs) required to meet requirements of the Food and Drug Administration (FDA), current Good Manufacturing Practices (cGMP) and 21 CFR Part 11.
Enhanced quality control capabilities in the QAD solution enhance product integrity across the global supply network -- from sourcing raw materials to distributing finished products -- with backward and forward traceability. This is particularly important for achieving regulatory requirements such as the emerging requirements for Unique Device Identification (UDI) compliance.